Association of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism

JAMAPublished Retrospective cohort study

Authors' conclusion

Adults with supernumerary sex chromosome aneuploidies compared with 2 sex chromosomes had a small but statistically significant increased risk of VTE. Further research is needed to understand the clinical implications of this association.

Study context

Population
White participants aged 18 to 90 years of the US Geisinger MyCode Community Health Initiative and the UK Biobank108,461 MyCode + 418,725 UK Biobank analysed for Venous Thromboembolism (VTE) · UK Biobank 488,025
Participants
642,544 participants
Exposure
Supernumerary sex chromosome aneuploidy vs 46,XX or 46,XY
Outcome
VTE: 1 primary inpatient VTE diagnosis, 2 primary outpatient VTE diagnoses, or a self-reported VTE diagnosis
Follow-up
10 years
Methodological details2 population-scale biobanks, P values adjusted for multiple comparisons
  • 2 population-scale biobanks
  • P values adjusted for multiple comparisons

Main finding

As reported in the abstract

Incident VTE, MyCode

Supernumerary SCA

1.3% per person-year

17 events

46,XX or 46,XY

0.25% per person-year

2060 events

Each group vs 46,XX or 46,XYHazard ratio (95% CI)P value
Supernumerary SCA
5.4(3.4–8.7)
P < 0.001
Each group vs 46,XX or 46,XY10-year risk difference (95% CI)P value
Supernumerary SCA
8.8%(4.2%–14.0%)
P < 0.001

Observational data: associations, not effects.

Further findings

Outcome46,XX or 46,XYHR (95% CI)P value
Incident VTE, UK Biobank · 10 years of follow-upSupernumerary SCAvs 46,XX or 46,XY0.11% per person-year4.1 (2.5–6.7)P < 0.001
Outcome10-year risk difference (95% CI)P value
Incident VTE, UK Biobank · 10 years of follow-upSupernumerary SCAvs 46,XX or 46,XY3.7% (1.4%–5.9%)P < 0.001
  • Incident VTE, UK Biobank: Supernumerary SCA 0.42% per person-year
  • Incident VTE, UK Biobank: 16 events per 3803 person-years vs 4491 per 3 970 467 person-years

Original publication

Association of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism. JAMA. Published 17 January 2023. doi:10.1001/jama.2022.23897

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.